Sputnik V Covid-19 vaccine approved by government panel for emergency use in India
An knowledgeable committee of the government has approved the Russian Covid-19 vaccine Sputnik V for emergency use in India.
The Drugs Controller General of India (DCGI) has already given nod to 2 COVID-19 vaccines — Covaxin of Bharat Biotech and Covishield of Oxford-AstraZeneca, being manufactured by the Serum Institute of India.
Sputnik V has demonstrated an efficacy fee of 91.6 per cent in the interim evaluation of part 3 medical trial, which included information on 19,866 volunteers in Russia.
